209 related articles for article (PubMed ID: 22447980)
1. Molecular mechanisms in the dramatic enhancement of HIV-1 Tat transduction by cationic liposomes.
Li GH; Li W; Mumper RJ; Nath A
FASEB J; 2012 Jul; 26(7):2824-34. PubMed ID: 22447980
[TBL] [Abstract][Full Text] [Related]
2. Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression.
Wang M; Yang W; Chen Y; Wang J; Tan J; Qiao W
Retrovirology; 2018 Sep; 15(1):65. PubMed ID: 30241541
[TBL] [Abstract][Full Text] [Related]
3. Macropinocytosis activated by oncogenic Dbl enables specific targeted delivery of Tat/pDNA nano-complexes into ovarian cancer cells.
Niu X; Gao Z; Qi S; Su L; Yang N; Luan X; Li J; Zhang Q; An Y; Zhang S
Int J Nanomedicine; 2018; 13():4895-4911. PubMed ID: 30214196
[TBL] [Abstract][Full Text] [Related]
4. BK channels regulate extracellular Tat-mediated HIV-1 LTR transactivation.
Khan N; Lakpa KL; Halcrow PW; Afghah Z; Miller NM; Geiger JD; Chen X
Sci Rep; 2019 Aug; 9(1):12285. PubMed ID: 31439883
[TBL] [Abstract][Full Text] [Related]
5. Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression.
Khan N; Halcrow PW; Lakpa LK; Rehan M; Chen X; Geiger JD
J Neurovirol; 2021 Oct; 27(5):755-773. PubMed ID: 34550543
[TBL] [Abstract][Full Text] [Related]
6. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
7. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
Zhang HS; Ruan Z; Sang WW
J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
[TBL] [Abstract][Full Text] [Related]
8. Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions.
Mishra A; Lai GH; Schmidt NW; Sun VZ; Rodriguez AR; Tong R; Tang L; Cheng J; Deming TJ; Kamei DT; Wong GC
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):16883-8. PubMed ID: 21969533
[TBL] [Abstract][Full Text] [Related]
9. Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.
Rahimian P; He JJ
J Neurovirol; 2016 Dec; 22(6):774-788. PubMed ID: 27173397
[TBL] [Abstract][Full Text] [Related]
10. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Zhang HS; Sang WW; Ruan Z; Wang YO
Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
[TBL] [Abstract][Full Text] [Related]
11. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
12. The 57th amino acid conveys the differential subcellular localization of human immunodeficiency virus-1 Tat derived from subtype B and C.
Zhao X; Qian L; Qi D; Zhou D; Shen W; Liu Y; Liu C; Kong X
Virus Genes; 2016 Apr; 52(2):179-88. PubMed ID: 26832332
[TBL] [Abstract][Full Text] [Related]
13. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
Chande AG; Baba M; Mukhopadhyaya R
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
[TBL] [Abstract][Full Text] [Related]
14. Cationic liposome-mediated uptake of human immunodeficiency virus type 1 Tat protein into cells.
Fong SE; Smanik P; Smith MC; Jaskunas SR
J Virol Methods; 1997 Jun; 66(1):149-57. PubMed ID: 9220401
[TBL] [Abstract][Full Text] [Related]
15. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.
Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH
J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079
[TBL] [Abstract][Full Text] [Related]
16. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
Schafer SL; Vlach J; Pitha PM
J Virol; 1996 Oct; 70(10):6937-46. PubMed ID: 8794337
[TBL] [Abstract][Full Text] [Related]
17. The uptake of HIV Tat peptide proceeds via two pathways which differ from macropinocytosis.
Ben-Dov N; Korenstein R
Biochim Biophys Acta; 2015 Mar; 1848(3):869-77. PubMed ID: 25542781
[TBL] [Abstract][Full Text] [Related]
18. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
[TBL] [Abstract][Full Text] [Related]
19. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
20. Y44A Mutation in the Acidic Domain of HIV-2 Tat Impairs Viral Reverse Transcription and LTR-Transactivation.
Szojka Z; Mótyán JA; Miczi M; Mahdi M; Tőzsér J
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
